PD-0456: Robustness of three stoichiometric CT-calibration parameterizations used in proton therapy  by Odén, J. et al.
3rd ESTRO Forum 2015                                                                                                                                         S223 
 
   
PD-0455   
Combined T2w volumetry, DW-MRI and DCE-MRI for 
response assessment after chemoradiation in rectal cancer 
M. Intven1, E.M. Monninkhof2, O. Reerink1, M.E.P. Philippens1 
1UMC Utrecht, Department of Radiotherapy, Utrecht, The 
Netherlands  
2UMC Utrecht, Julius Center for Health Sciences and Primary 
Care, Utrecht, The Netherlands  
 
Purpose/Objective: Organ sparing treatment is gradually 
becoming an option for patients with locally advanced rectal 
cancer (LARC) with good clinical response after neo-adjuvant 
chemoradiation (CRT). However, patient selection for organ 
sparing treatment is challenging and there is no standard of 
care restaging procedure after CRT. Functional MR imaging, 
diffusion weighted MRI (DW-MRI) and dynamic contrast 
enhanced MRI (DCE-MRI) showed promising results in earlier 
studies. In this study, we assessed the value of combined T2 
weighted MRI (T2w) volumetry, DW-MRI and DCE-MRI for 
pathological response prediction after neo-adjuvant CRT in 
patients with LARC.  
Materials and Methods: Patients received MRI with DW-MRI 
and DCE-MRI sequences before start of CRT and before 
surgery. After surgery, the tumor regression grade (TRG) was 
obtained based on the score by Mandard et al. Pathological 
complete responders (pCR, Mandard 1) were compared with 
non-pCR patients. Besides, patients with a good response, GR 
(Mandard 1+2) were compared with patients with a non-GR.  
Results: From the 55 patients analyzed in the study, six 
showed a pCR (10.9%) and 10 had a GR (18.6%). Favorable 
responders had a larger decrease in tumor volume, a larger 
increase in Apparent Diffusion Coefficient (ADC) values and a 
larger decrease in Ktrans compared to non-responders. ADC 
change showed the best accuracy for diagnoses of pCR. For 
GR, the model including ADC change and volume change 
showed the best diagnostic performance. Inclusion of Ktrans 
change did not increase the diagnostic values for pathological 
favorable response.  
 
Table 1: Diagnostic values for the diagnosis of pathological 
complete response (pCR) and pathological good response (GR) 
for the different models. In the individual parameter models 
the optimal cut-off values for Δvolume, ΔADC and ΔKtrans 
were -74%, +44% and -32%, respectively. Abbreviation: ADC = 
apparent diffusion coefficient, AUC = area under the receiver 
operating curve, PPV = positive predictive value and NPV = 
negative predictive value. 
 
Figure 1: receiver operating characteristic (ROC) curves for 
models with the best diagnostic accuracy for pathological 
complete reseponse (pCR, left) and pathological good 
response (GR, right).  
Conclusions: This explorative study showed that ADC 
decrease is a promising diagnostic tool for pCR and the 
combination of ADC and volume decrease for GR in patients 
with LARC after neo-adjuvant CRT. Ktrans change showed no 
additional value. These results justify further research in a 
larger prospective study with DW-MRI and tumor volumetry.  
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Purpose/Objective: The use of a stoichiometric CT-
calibration has become the standard method for converting 
CT-numbers to relative proton stopping-power-ratios (SPR) 
worldwide. However, several different parameterizations for 
the calibration have been published and the aim of this 
project is to assess accuracy and robustness of the CT-
calibration for three different parameterizations. 
Materials and Methods: Phantom model 062M from CIRS 
(Norfolk, VA, USA) with a fixed distribution of inserts with 
known mass density and elemental composition was scanned 
daily over a period of two months with a 120 kVp clinical 
protocol on a Siemens Definition AS+ to determine the 
variation of the CT-numbers. Repeated calibration scans with 
the inserts positioned centrally in a homogenous phantom, 
one by one, were performed to determine stable mean CT-
numbers.Three published stoichiometric parameterizations 
using 1, 2 or 3 fitting parameters were evaluated by 
simulating random changes in the measured mean CT-
numbers based on the measured variation. CT-numbers for 72 
theoretical tissue compositions were then calculated for each 
simulation. The resulting mean values and SD were plotted 
against their Bethe-Bloch calculated SPR for 100 MeV protons. 
Finally the mean-calibration curve was determined for each 
parameterization using piecewise connection of weighted 
linear regressions within each tissue group. 
Results: The measured SD for the inserts was 1-5 HU (mean 
SD 2.7 HU). 10000 simulations of the stoichiometric 
calibration were performed for each parameterization, using 
a normal distribution with the measured mean values and a 
standard deviation of 3 HU for the inserts. The resulting RMSE 
was similar between the three methods for all simulations. 
For each method the resulting mean-calibration curve is 
plotted in Figure 1a together with the mean CT-number and 
SD (horizontal error bars) for the 72 theoretical tissues. The 
curves from the methods using 2 and 3 fitting parameters are 
more or less inseparable throughout the whole CT-range, 
whereas the 1-fitting parameter method differ somewhat in 
the dense bone region. The largest disagreement is 18 HU for 
cortical bone (#72). This corresponds to 0.6% difference in 
SPR for a HU of 1200. The SD of the calculated CT-numbers is 
presented separately in Figure 1b. The method using 3 fitting 
parameters have significantly larger SD compared to the 
other two methods, especially for bony tissues. 
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Conclusions: A stoichiometric calibration is feasible using all 
three parameterizations. The resulting mean-calibration 
curves are similar for all three methods. However, when 
introducing a random variation in the measured CT-numbers, 
as is manifest daily from scan to scan, the parameterization 
using 3 fitting parameters demonstrates significantly larger 
variation in the calculated CT-numbers of the theoretical 
tissues. The impact of this to the uncertainty in the proton 
ranges in human tissues will be studied further.  
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Purpose/Objective: Detailed knowledge of the esophageal 
tumor boundary is currently lacking. This uncertainty leads to 
large margins and risk of geographic miss during irradiation. 
Optical coherence tomography (OCT) is a minimally invasive 
and high resolution (1-10 µm) imaging technique that obtains 
cross-sectional images of tissue based on the backscattering 
of light. OCT has a great potential for esophageal cancer, as 
cylindrical probes exist that can scan the surface using a 
single rotating optical fiber. Fiducial markers have been 
successfully applied in a variety of treatment sites to provide 
guidance during tumor delineation and setup verification. 
Recently, we successfully placed markers at the proximal and 
distal tumor borders in esophageal cancer patients. 
Integration of the OCT with the CT used for treatment 
planning is an unsolved problem. Visibility of markers on OCT 
is crucial for an accurate registration of the OCT with the 
planning CT. This study aimed to investigate the visibility on 
OCT of two commercially available gold markers at 3 
different depths; enabling registration with CT.  
Materials and Methods: OCT is similar to ultrasound, 
however, it uses near infrared light instead of sound. While 
OCT has a 10 times higher resolution than ultrasound, it 
suffers from a limited penetration depth in the range of 2-3 
mm. We designed and manufactured a dedicated esophageal 
phantom, in which 3 different scattering materials represent 
esophageal wall layers (figure 1.A). Visicoil and Gold Anchor 
markers were implanted at different depths (≤0.2 mm, 0.6 
mm, and 1.2 mm) and imaged using an endoscopic OCT 
imaging system (Nvision VLE Imaging System, NinePoint 
Medical, Inc.). Further, to evaluate whether in current 
clinical practice the fiducial markers are placed within the 
OCT visualization range; we retrospectively measured the 
distance between the implanted gold markers and the inner 
wall of the esophagus on the planning CT of 7 patients who 
underwent endoscopy-guided marker implantation. 
Additionally, we manually coregistered the phantom OCT and 
CT images with use of the markers. 
Results: Figure 1.B shows that both types of gold markers are 
visible on OCT at all tested depths. Different scattering 
materials are visible on OCT. CT measurements from 7 
patients (9 fiducial markers) yield that on average the 
markers were implanted at a depth of 1.7 mm (range: 0.7-6.3 
mm) in the esophageal wall (table 1). For the 9 fiducial 
markers included in our retrospective analysis, 89% of the 
markers were placed at depths ≤2.0 mm and 44% were placed 
at depths ≤1.2 mm. Manual coregistration based on 2 markers 
was feasible (figure 1.C.). 
 
 
 
 
 
Conclusions: We have designed and manufactured a 
dedicated esophageal phantom, enabling the study of the 
visibility of two types of gold markers at different depths on 
OCT. The results indicate that both Visicoil and Gold Anchor 
markers are visible on OCT at depths ≤1.2 mm. Also, based 
on CT measurements, the majority of the markers in current 
clinical practice are already placed within the OCT 
visualization range. 
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